Quality of pharmacoeconomic research in China: A systematic review

about

Quality of pharmacoeconomic research in China: A systematic review

Item

http://www.wikidata.org/entity/Q37354823

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quality of pharmacoeconomic research in China: A systematic review

@en

Quality of pharmacoeconomic research in China: A systematic review.

@nl

type

Item

label

Quality of pharmacoeconomic research in China: A systematic review

@en

Quality of pharmacoeconomic research in China: A systematic review.

@nl

prefLabel

Quality of pharmacoeconomic research in China: A systematic review

@en

Quality of pharmacoeconomic research in China: A systematic review.

@nl

P1476

Quality of pharmacoeconomic research in China: A systematic review

@en

P2093

Hai Fang

http://www.w3.org/2001/XMLSchema#string

Huifen Ma

http://www.w3.org/2001/XMLSchema#string

John A Rizzo

http://www.w3.org/2001/XMLSchema#string

Tingting Xu

http://www.w3.org/2001/XMLSchema#string

Weiyan Jian

http://www.w3.org/2001/XMLSchema#string

Yasheng He

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Are Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?: A Systematic Review and Meta-Analysis

A trial-based cost-effectiveness analysis of erlotinib alone versus platinum-based doublet chemotherapy as first-line therapy for Eastern Asian nonsquamous non-small-cell lung cancer

A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups.

Cost-effectiveness of Store-and-Forward Teledermatology: A Systematic Review.

The quality of reporting in published cost-utility analyses, 1976-1997.

Economic evaluation of first-line treatments for metastatic renal cell carcinoma: a cost-effectiveness analysis in a health resource-limited setting.

Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association.

Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.

Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.

Gene-guided gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive non-small cell lung cancer: an economic analysis

P304

e5114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1097/MD.0000000000005114

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27741131

http://www.w3.org/2001/XMLSchema#string

P932

5072958

http://www.w3.org/2001/XMLSchema#string